Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | -11.22% | -19.07% | -3.06% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Eterna Therapeutics Inc.
Upcoming events on Eterna Therapeutics Inc.
No events available
Past events on Eterna Therapeutics Inc.
2023-06-16 11:00 am | Annual General Meeting |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 1563 |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 1516 |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 1314 |
2023-05-19 03:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract & Poster Board Number: 1262 |
2023-05-18 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 1103 |
2023-05-18 03:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract & Poster Board Number: 1065 |
2023-05-17 09:00 pm | American Society of Gene Cell Therapy Meeting |
2023-05-17 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 616 |
2023-05-17 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract & Poster Board Number: 563 |
2022-10-16 | Reverse Split: 1 of 20 |
2022-09-21 11:00 am | Annual General Meeting |
2022-04-15 04:15 pm | FY 2021 Earnings Release |
2021-12-09 11:20 am | MedInvest Oncology Investor Conference |
2021-12-08 04:40 pm | Benzinga Global SmallCAP Conference |
2021-11-08 | Q3 2021 Earnings Release |
2021-09-20 04:30 pm | Business Update Call |
2021-08-20 09:00 am | Annual General Meeting |
2021-08-19 04:30 pm | Business Update Call |
2021-08-18 12:00 pm | SNN Virtual Investor Conference |
Annual results
Fiscal Period | December | 2021 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -114 -111 -2.37% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -122 -120 -1.65% |
Net income Million USD | Released Forecast Spread | -122 -120 -1.66% |
EPS USD | Released Forecast Spread | -56,4 -56,0 -0.71% |
Announcement Date | 15/04/22 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -9,11 -6,50 -40.08% | -6,30 -7,68 18.07% | -13,9 -6,65 -108.85% | -8,30 -6,55 -26.78% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,46 -6,50 -30.12% | -9,38 -6,37 -47.2% | -3,41 -6,65 48.75% | -7,31 -6,55 -11.62% |
Net income Million USD | Released Forecast Spread | -8,48 -6,50 -30.45% | -9,38 -6,37 -47.2% | -3,41 -6,65 48.75% | -7,32 -6,55 -11.69% |
EPS USD | Released Forecast Spread | 0,00 -2,50 - | -3,40 -2,40 -41.67% | -1,20 -2,60 53.85% | -2,49 -2,20 -13.18% |
Announcement Date | 15/04/22 | 01/07/22 | 11/08/22 | 14/11/22 |
Past sector events for Eterna Therapeutics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ERNA Stock
- Calendar Eterna Therapeutics Inc.